肥胖相关性高血压
Obesity-related hypertension.
作者信息
Re Richard N
机构信息
Hypertension Section, Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA.
出版信息
Ochsner J. 2009 Fall;9(3):133-6.
Abstract
Obesity-associated arterial hypertension is characterized by activation of the sympathetic nervous system, activation of the renin-angiotensin system, and sodium retention, among other abnormalities. In this review, the following 3 facets of the obesity/hypertension nexus will be discussed: the potential mechanisms by which obesity can lead to elevated arterial pressure, the interaction of obesity with the sequelae of hypertension, and the therapies that are believed to optimally treat obesity-related hypertension.
摘要
肥胖相关的动脉高血压的特征是交感神经系统激活、肾素-血管紧张素系统激活以及钠潴留等异常情况。在本综述中，将讨论肥胖/高血压关系的以下三个方面：肥胖导致动脉血压升高的潜在机制、肥胖与高血压后遗症的相互作用，以及被认为能最佳治疗肥胖相关高血压的疗法。
相似文献
1
Obesity-related hypertension.肥胖相关性高血压
Ochsner J. 2009 Fall;9(3):133-6.
2
Leptin, Obesity, and Hypertension: A Review of Pathogenetic Mechanisms.瘦素、肥胖与高血压：发病机制的综述。
Metab Syndr Relat Disord. 2020 Nov;18(9):399-405. doi: 10.1089/met.2020.0065. Epub 2020 Sep 1.
3
Is there a rationale for angiotensin blockade in the management of obesity hypertension?在肥胖型高血压的治疗中，使用血管紧张素阻滞剂是否有理论依据？
Hypertension. 2004 Jul;44(1):12-9. doi: 10.1161/01.HYP.0000132568.71409.a2. Epub 2004 Jun 1.
4
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Obesity: a common prime mover of chronic activation of the sympathetic nervous system and the renin-angiotensin system in systemic hypertension?关于“针锋相对”观点的评论：系统性高血压的主要促成因素：交感神经系统的慢性激活与肾内肾素 - 血管紧张素系统的激活。肥胖：系统性高血压中交感神经系统和肾素 - 血管紧张素系统慢性激活的常见主要推动者？
J Appl Physiol (1985). 2010 Dec;109(6):2008-9. doi: 10.1152/japplphysiol.01160.2010.
5
Sodium and obesity in the pathogenesis of hypertension.高血压发病机制中的钠与肥胖
Am J Hypertens. 1990 Feb;3(2):164-7. doi: 10.1093/ajh/3.2.164.
6
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.肥胖相关性高血压中的肾素-血管紧张素系统和利钠肽
J Mol Med (Berl). 2001;79(1):21-9. doi: 10.1007/s001090000144.
7
The role of the sympathetic nervous system in obesity-related hypertension.交感神经系统在肥胖相关高血压中的作用。
Curr Hypertens Rep. 2009 Jun;11(3):206-11. doi: 10.1007/s11906-009-0036-3.
8
Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.交感神经活动增强导致糖尿病肥胖 Zucker 大鼠出现高血压和盐敏感性。
Hypertension. 2000 Jan;35(1 Pt 2):403-8. doi: 10.1161/01.hyp.35.1.403.
9
Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.病态肥胖、高血压疾病与肾素-血管紧张素-醛固酮轴
Obes Surg. 2005 May;15(5):670-6. doi: 10.1381/0960892053923734.
10
Mechanisms of abnormal renal sodium handling in obesity hypertension.肥胖相关性高血压中肾脏钠代谢异常的机制
Am J Hypertens. 1997 May;10(5 Pt 2):49S-55S.
引用本文的文献
1
Relationship between body mass index and cardiometabolic health in a multi-ethnic population: A project baseline health study.多民族人群中体重指数与心脏代谢健康的关系：一项项目基线健康研究。
Am J Prev Cardiol. 2024 Mar 16;18:100646. doi: 10.1016/j.ajpc.2024.100646. eCollection 2024 Jun.
2
Associations between body composition and cardiovascular disease risk in pre- and postmenopausal women.绝经前和绝经后妇女的身体成分与心血管疾病风险之间的关联。
J Health Popul Nutr. 2023 Oct 17;42(1):110. doi: 10.1186/s41043-023-00455-6.
3
The synthesis and evaluation of thiolated alginate as the barrier to block nutrient absorption on small intestine for body-weight control.硫醇化海藻酸盐作为小肠营养吸收阻滞剂用于体重控制的合成与评价。
Bioeng Transl Med. 2022 Aug 12;8(5):e10382. doi: 10.1002/btm2.10382. eCollection 2023 Sep.
4
Capybara Oil Improves Renal Pathophysiology and Inflammation in Obese Mice.水豚油可改善肥胖小鼠的肾脏病理生理学和炎症反应。
Nutrients. 2023 Jun 28;15(13):2925. doi: 10.3390/nu15132925.
5
The effect of angiotensin converting enzyme gene insertion/deletion polymorphism on anthropometric and biochemical parameters among hypertension patients: A case-control study from Northwest Ethiopia.血管紧张素转换酶基因插入/缺失多态性对高血压患者人体测量学和生化参数的影响：来自埃塞俄比亚西北部的一项病例对照研究。
PLoS One. 2023 May 18;18(5):e0285618. doi: 10.1371/journal.pone.0285618. eCollection 2023.
6
Benefits of Physical Activity on Cardiometabolic Diseases in Obese Children and Adolescents.体育活动对肥胖儿童和青少年心血管代谢疾病的益处。
J Transl Int Med. 2022 Sep 30;10(3):236-245. doi: 10.2478/jtim-2022-0041. eCollection 2022 Sep.
7
Cognition and brain oxygen metabolism improves after bariatric surgery-induced weight loss: A pilot study.减重手术引起的体重减轻后认知和大脑氧代谢改善：一项初步研究。
Front Endocrinol (Lausanne). 2022 Dec 9;13:954127. doi: 10.3389/fendo.2022.954127. eCollection 2022.
8
Association of angiotensin-converting enzyme gene insertion/deletion polymorphisms with risk of hypertension among the Ethiopian population.血管紧张素转换酶基因插入/缺失多态性与埃塞俄比亚人群高血压风险的关联。
PLoS One. 2022 Nov 10;17(11):e0276021. doi: 10.1371/journal.pone.0276021. eCollection 2022.
9
Metoprolol Inhibits Developmental Brain Sterol Biosynthesis in Mice.美托洛尔抑制小鼠发育中的大脑固醇生物合成。
Biomolecules. 2022 Aug 31;12(9):1211. doi: 10.3390/biom12091211.
10
Comparison of Blood Pressure and Pulse Adaptations Between Younger and Older Patients During Balneotherapy With Physiotherapy.年轻与老年患者在温泉疗法结合物理治疗期间血压和脉搏适应性的比较
J Chiropr Med. 2022 Sep;21(3):197-203. doi: 10.1016/j.jcm.2022.02.012. Epub 2022 Jun 6.
本文引用的文献
1
Modulation of blood pressure by central melanocortinergic pathways.中枢黑皮质素能通路对血压的调节
N Engl J Med. 2009 Jan 1;360(1):44-52. doi: 10.1056/NEJMoa0803085. Epub 2008 Dec 17.
2
Sympathetic neural mechanisms in human hypertension.人类高血压中的交感神经机制。
Curr Hypertens Rep. 2008 Jun;10(3):241-7. doi: 10.1007/s11906-008-0045-7.
3
Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart Study).儿童期危险因素与相对年轻时左心室肥厚（离心性或向心性）的关系（来自博加卢萨心脏研究）
Am J Cardiol. 2008 Jun 1;101(11):1621-5. doi: 10.1016/j.amjcard.2008.01.045. Epub 2008 Apr 2.
4
Dysregulation of the endocannabinoid system in obesity.肥胖症中内源性大麻素系统的失调。
J Neuroendocrinol. 2008 May;20 Suppl 1:110-5. doi: 10.1111/j.1365-2826.2008.01683.x.
5
Blood pressure lowering effects of rimonabant in obesity-related hypertension.利莫那班对肥胖相关性高血压的降压作用
J Neuroendocrinol. 2008 May;20 Suppl 1:63-8. doi: 10.1111/j.1365-2826.2008.01688.x.
6
Endocannabinoids, blood pressure and the human heart.内源性大麻素、血压与人类心脏
J Neuroendocrinol. 2008 May;20 Suppl 1:58-62. doi: 10.1111/j.1365-2826.2008.01677.x.
7
Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.肾素-血管紧张素系统、利钠肽、肥胖、代谢综合征与高血压：人类综合视角
J Hypertens. 2008 May;26(5):831-43. doi: 10.1097/HJH.0b013e3282f624a0.
8
Management of arterial hypertension in obese patients.肥胖患者动脉高血压的管理。
Curr Hypertens Rep. 2007 Dec;9(6):491-7. doi: 10.1007/s11906-007-0090-7.
9
Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan.血管紧张素II受体阻滞剂替米沙坦在治疗合并心脏代谢综合征个体高血压中的作用
Expert Rev Cardiovasc Ther. 2008 Mar;6(3):289-303. doi: 10.1586/14779072.6.3.289.
10
Weight reduction for treatment of obesity-associated hypertension: nuances and challenges.减重治疗肥胖相关性高血压：细微差别与挑战
Curr Hypertens Rep. 2007 Nov;9(5):368-72. doi: 10.1007/s11906-007-0068-5.
Zotero 插件